MedPath

Transillumination Device for Peripheral Intravenous Placement in Patients With Sickle Cell Disease (PERFID)

Not Applicable
Completed
Conditions
Sickle Cell Crisis
Interventions
Other: Routine procedure
Device: Accuvein V400 device
Registration Number
NCT03477552
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Brief Summary

The primary goal of this randomized, controlled, open-label study is to determine the efficacy of AccuveinV400 (a transillumination veins device) to facilitate peripheral intravenous (IVP) catheter placement during a vaso-oclusive crisis. The investigators hypothesized that the number of attempts to a successful placement of a peripheral IV, our primary outcome, would be shorter with the assistance of the Accuvein V400. It is also expected that AccuveinV400 will reduce the time of the procedure, the rate of failure, the technique-related pain.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
126
Inclusion Criteria
  • Sickle cell patients (all genotypes)
  • Patients hospitalized for uncomplicated vaso-occlusive crisis (CVO) in Internal/general Medicine department
  • Patients requiring the placement or replacement of a peripheral intra-venous catheter in the Department of Internal/general Medicine
  • Patients arrived in the internal/general medicine department of the hospital between 9h and 18h and except weekends
  • Signed informed consent.
  • Affiliated to the French health care insurance.
Exclusion Criteria
  • Signs of shock
  • Acute chest Syndrome
  • Central venous catheter already present
  • Indication to have a central venous catheter from the ourset
  • Patient who has already participated to the PERFID study during the current hospitalization
  • Refusal of the patient's participation
  • Pregnant or lactating woman
  • Patient under guardianship or curatorship

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Routine procedureRoutine procedureIn the control group, the nurse proceeds as usual to infuse the patient (visual identification in the light of the chamber and palpation)
Accuvein V400 deviceAccuvein V400 deviceIn the Accuvein group, the nurse uses the Accuvein device to identify the veins before any puncture to infuse the patient and then proceeds as usual, under illumination of the device.
Primary Outcome Measures
NameTimeMethod
Number of venipuncturesTime of the infusion procedure

Number of venipunctures until the peripheral IV placement (with a retrograde blood sample) or before failure (discontinuation after at least 3 attempts by 2 nurses and a maximum of 9 attempts in total).

Secondary Outcome Measures
NameTimeMethod
The need of a central venous catheterTime of the infusion procedure

Percentage of use of a central venous catheter due to failure of peripheral perfusion.

Anxiety before and after the procedureJust before and within 1 hour after a successful peripheral IV placement

Patient and nurse anxiety will be evaluated by a visual 5 points-Likert scale (between 1=not at all anxiety to 5=extremely anxious) of anxiety before and after the procedure

Patient satisfaction (pain)Within 1 hour after a successful peripheral IV placement

Patient pain related to the procedure will be evaluated by Visual Analogue Scale (between 0=no pain to10=intolerable pain)

Qualitative interview of the Accuvein useAn average of one week after the procedure

Verbatim of a semi-structured interview by a psychologist of 10 to 15 patients (and their nurse) often hospitalized, in the Accuvein Arm

Patient bone pain before and after the procedureBefore and within 1 hour after a successful peripheral IV placement

Patient bone pain will be evaluated by Visual Analogue Scale (between 0=no pain to10=intolerable pain) before and after the infusion procedure

Nurse satisfaction (procedure)Within 1 hour after a successful peripheral IV placement

Nurse global satisfaction of the procedure will be evaluated by Likert scale (between 1=not at all anxiety to 5=extremely anxious)

Nurse satisfaction (quality of placement)Within 1 hour after a successful peripheral IV placement

Nurse satisfaction of the quality of the peripheral intravenous placement will be evaluated by Likert scale (between 1=not at all anxiety to 5=extremely anxious)

Side effects of the procedureTime of the infusion procedure

Complication rate of the peripheral venous catheter procedure (hematoma, bleeding, malaise).

Time of the procedureTime of the infusion procedure

Time from the tourniquet inflation to the insertion of the catheter with a retrograde blood sample was recorded with a chronometer

Patient satisfaction (procedure)Within 1 hour after a successful peripheral IV placement

Patient satisfaction of the procedure will be evaluated by a visual 5-points Likert scale (between 1=not at all anxiety to 5=extremely anxious) of satisfaction of the procedure

Procedure failureTime of the infusion procedure

Percentage of the procedure failure

Trial Locations

Locations (2)

AP-HP - Hopital Europeen Georges-Pompidou Paris, France

🇫🇷

Paris, Ile-de-France, France

CHU H. Mondor

🇫🇷

Créteil, France

© Copyright 2025. All Rights Reserved by MedPath